Quantitative evaluation of HSPA5 mRNA in affected samples of IBD patients revealed an increase of 2.6-fold in UC (p = 0.0002) and 2.5-fold in colonic CD (p = 0.0003) when compared to healthy controls (Fig. 2A). Here, HSPA5 is linked to inflammatory bowel disease.